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Predictors for operative mortality (OM) were studied in 172 consecutive patients (pts) undergoing
coronary artery grafts (CAG) for angina pectoris.
Seventy eight pts had Class IV angina; ofthe 147 patients given propranolol, 41 were gradually with-
drawn from propranolol and finally discontinued 24 hours before surgery, and 106 were abruptly with-
drawn from propranolol 24 hours before CAG; 20 pts had left main coronary disease; 156 pts had cardio-
pulmonary bypass (CPB) time shorterthan 20minutes, and 16pts had aCPB longerthan 120 minutes.
The operative mortality was 5.2% (9/172) for the entire group. Class IV angina (OM 7%), abrupt pro-
pranolol withdrawal (OM 6.6%), left main coronary artery disease (OM 25%), and CPB longer than 120
minutes (OM 50%o), all significantly increased OM. These variables were interdependent, however, as
many pts belonged to several predictor categories, combinations ofpredictors were examined, in orderto
more accurately predict the risk of individual pts. The combination ofleft main coronary artery disease
andCPB longerthan 120minutes; andClass IVanginaand CPB longerthan 120minuteswere significantly
associated with higher operative mortality.
WeconcludethatClass IVangina, abruptpropranololwithdrawal, leftmaincoronaryartery diseaseand
prolonged CPB are potent, interdependent predictors of OM in pts undergoing CAG. Consideration of
these predictors, alone and in combination, allows effective prediction ofOM for CAG in patients with
stable angina pectoris.
INTRODUCTION
Coronary artery bypass surgery is now awidely usedapproach to the treatment
ofarteriosclerotic heart disease in selectedpatients. Afew studies have suggested
short-term reliefofangina [1-3] and anincrease inlongevity [4]. Furtherfollow-up
is necessary before the effects ofthe operation can fully be evaluated.
In this report we present an analysis of clinical, anatomic, hemodynamic and
operative factors affecting operative mortality in 172 consecutive patients. These
patients underwent cardiac catheterization and coronary artery bypass grafts
without associated surgical procedures at Yale-New Haven Hospital from July
1974toJune 1975. Dataoneachpatient wereprospectivelycollected and analyzed
to identify those preoperative factors which couldpredict the immediate outcome
of individual patients.
METHODS
From July 1974 to June 1975, 172 consecutive patients underwent cardiac
catheterization and coronary bypass grafts for treatment of angina pectoris
refractory to medical therapy. Diagnostic cardiac catheterization consisted of
pressuremeasurements, cardiacoutputdetenrnination, singleplaneventriculogram
and selective coronary cinearteriography, all performed by standard techniques.
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All rights of reproduction in any form reserved.Coronary artery lesions of greater than 70 percent obstruction were classified as
significant. Coronary artery disease was recorded as one, two or three vessel
disease. Left main coronary artery disease (LMCD) was considered equivalent to
disease ofthe proximal left anteriordescending artery and proximal left circumflex
artery. Diffuse disease of a coronary artery was determined by the presence of
several lesions with greater than one cm in length and more than 70 percent
narrowing ofthe arterial lumen. The right anterior oblique left ventriculogram was
analyzed forcalculation ofejection fraction according to the method ofGreene [5],
and for the presence of mitral regurgitation.
Coronary artery surgery was performed within three weeks following cardiac
catheterization in allpatients. In one group ofpatients, no propranolol therapy was
used preoperatively; in a second group, propranolol doses were gradually de-
creased (during ameanperiodofthree days) andfinally discontinued 24hoursprior
to surgery; and in a third group, propranolol was abruptly discontinued 24 hours
before surgery. Coronary artery bypass grafts were performed using saphenous
veins to graft the posterior descending artery and marginal branch of the left
circumflex coronary artery. The left internal mammary artery was used whenever
possible to graft the left anterior descending artery. Dissection of the internal
mammaryarteries fromthe chest wall andproximal anastomoses ofsaphenous vein
graftswerebothaccomplished without cardiopulmonary bypass. Sidebitingclamps
were employed for proximal anastomoses of saphenous vein to the aorta. Distal
anastomoses were done on full cardiopulmonary bypass with the heart in ventri-
cularfibrillation; aortic cross-clamping was used only when adry field could not be
obtained by local occlusion ofthe coronary artery. Revascularization was consid-
ered "incomplete" ifgrafts were notplaced in every diseased coronary branch. For
the purpose ofthis study, operative mortality was defined as death occurring up to
six weeks after surgery was performed. The period of six weeks was selected
because itappeared to be the natural cut-offpoint between early and late mortality.
Statistical Methods
Contingency table chi-square (X2) [6] was used to examine the possible relation-
ship of each study factor to operative mortality. Although the factors relating to
operative mortality were not necessarily independent influences, they were
initially examined one at a time and then in combinations. Statistical significance
was attributed to a P value of less than 0.05.
When information on some preoperative clinical characteristic of a patient was
not available, that patient was not included in the analysis ofthat variable.
Characteristics ofPatients
The average age ofthe patients was 55.4 years (range 31 to 76), and 78 percent
(134/172) were male. Associated peripheral disease was present in 24 patients (14
percent); diabetes mellitus in 24 patients (14 percent); and lipid abnormality in 47
patients (31 percent). Other characteristics included: family history of ischemic
heart disease in 108 patients (66 percent); hypertension in 57 patients (33 percent);
obesity [7] in 90 patients (54 percent); and smoking history in 138 patients (80
percent). In addition, there were one hundred and two patients with remote
myocardial infarction (59 percent) and nine with recent myocardial infarction,
occurring less then three months prior (5 percent). Nine patients (5 percent) had
angina pectoris Class I NYHA; 24 (14 percent) had Class II; 61(35 percent) had
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TABLE 1
Characteristics of Patients by Medical History and Physical Examination
Patients with Characteristic
Characteristics Total Patients
(no.) (no.) (%)
Peripheral VascularDisease 170 24 14
DiabetesMellitus 170 24 14
LipidAbnonnality 151 47 31
FamilyHistory 164 108 66
Hypertension 171 57 33
Obesity 167 90 54
RemoteMyocardialInfarction 172 102 59
RecentMyocardialInfarction 172 9 5
AnginalStatus
Class I 172 9 5
Class II 172 24 14
Class III 172 61 35
Class IV 172 78 45
CongestiveHeartFailure 172 26 15
B-AdrenergicTherapy
NoTherapy 172 25 14
< 160mg. q.d. 172 56 32
. 160mg. q.d. 172 91 53
Class III; and 78(45percent) had Class IV. Congestive heartfailure waspresent in
26 patients (15 percent), and only 25 patients (14 percent) had not received beta
blocking therapy (Table 1).
TABLE 2
Characteristics of Patients by Chest X-ray and Cardiac Catheterization
Patients with Characteristic
Characteristic Total Patients
(no.) (no.) (%)
CardiacEnlargement 172 32 19
LVEDP*
< 12mmHg. 172 93 54
13-17mmHg. 172 41 24
2 18mmHg. 172 38 22
Ejection Fraction
a0.60 172 109 63
0.30-0.59 172 62 36
<0.30 172 1 1
Mitral Regurgitation 172 22 13
Numberofvesselsdiseased
One 172 22 13
Two 172 44 26
Three 172 106 62
LeftMainCoronary 172 20 12
Artery Disease
*Refers to left ventricular end-diastolic pressure.LANGOU ETAL.
Cardiac enlargement, (CT ratio > 50 percent) measured by standard upright
chest x-ray, was present in 32 patients (19 percent); normal left ventricular end-
diastolic pressure (c 12 mm Hg) was recorded in 93 patients (54 percent); and
normal ejection fraction (- 60 percent) in 109 patients (63 percent). Mitral
regurgitation documented by left ventriculography was present in 22 patients (13
percent). Coronary arteriography in this group ofpatients revealed 22 patients (13
percent) with single vessel disease; 44 patients (26 percent) with double vessel
disease; and 106patients(62percent)withtriplevesseldisease. Leftmaincoronary
artery narrowing was documented in 20 patients (12 percent), (Table 2).
Ofthe 147patients given propranolol, 41 (28percent)weregraduallywithdrawn
frompropranololandfinallydiscontinued24hoursbefore surgery;and 106patients
(72 percent) were abruptly withdrawn from propranolol 24 hours before coronary
artery surgery. Thedailydoseofpropranololwaslessthan 160mgin56patients(32
percent) andmorethan 160mgin91patients (53percent). Foronehundredfifty-six
patients (91 percent) the cardiopulmonary bypass (CPB)timewas shorterthan 120
minutes. Seventy-three patients (42 percent) underwent complete revasculariza-
tion; 27 had single bypass graft; 86 had double grafts; and 59 had triple or more
grafts.
RESULTS
The overall operative mortality for this group ofpatients was 5.2 percent (nine
deaths among 172consecutivepatients). Noneofthepatientsdiedontheoperative
day; sevenpatientsdiedwithinthefirstweek, andoneinthefourthweekandonein
the sixth week postoperatively. Six ofthese deaths were attributed to periopera-
tive myocardial infarction as documented by serial electrocardiograms and/or
autopsy; one due to ventricular fibrillation without anatomical documentation of
acute myocardial necrosis; and two others due to non-cardiac causes.
Factors Related to Operative Mortality
Fourfactors appeared tobe related tooperative mortality (OM): anginapectoris
ClassIVNYHA;abruptpropranololwithdrawal;leftmaincoronaryarterydisease;
and cardiopulmonary bypass time longer than 120 minutes. Patients with angina
pectoris Class IV showed a significantly higher mortality than those with angina
pectorisClass III orless(7percent,7/78 vs. 2.0percent2/94 [p <0.05]). Patients in
whompropranololtherapy wasabruptlydiscontinued24hourspriorto surgeryhad
a risk ofdying which was more than two times as great (6.6 percent) as those in
whompropranolol therapyhadbeengraduallyreducedoverathree-dayperiodand
finally discontinued 24 hours before surgery (2.4 percent). Patients with left main
coronary artery disease (LMCD) sustained operative risks 10 times greater than
those patients without LMCD (25 percent vs. 2.6 percent [p < 0.001]), as seen in
Table 3. Finally, patients whose CPB time was longerthan 120 mlnutes showed a
mortality of50 percent, afigure which is significantly higher than that ofpatients
withCPBtime shorterthan 120minutes (Table4). Forall 16patientswithCPBtime
longer than 120 minutes, severe diffuse distal disease was present in arteries
receiving bypass grafts.
Ananalysisofotherprobablepreoperative riskfactorsforoperativemortalityby
contingency table chi-square (X2) showed that operative mortality was not related
toage, sex,peripheralvasculardisease, diabetesmellitus, lipidabnormality,family
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TABLE 3
Risk Factors as Related to Operative Mortality
Total Number of Patients PercentMortality p Factors
Patients
With Without With Without
Value
Factor Factor Factor Factor
AnginaClassIV 172 78 94 7.0 2.0 <0.05
PropranololTherapy
AbruptWithdrawal 147 106 41 6.6 2.4 <0.05
LeftMainCoronary 172 20 152 25.0 2.6 <0.001
ArteryDisease
TABLE 4
Operative Mortality: Duration of Cardiopulmonary Bypass
Deaths
Group TotalPatients
Number Percent
< 90min. 119 0 0
90-1 l9min. 37 1 2.7
2120min. 16 8 50.0*
AllGroups 172 9 5.2
*p < 0.001
history ofischemic heartdisease, hypertension, obesity, smokinghabits, previous
myocardial infarction, congestive heartfailure, heartsize, leftventricularend-dia-
stolic pressure, ejection fraction, or mitral regurgitation, or number of diseased
vessels (except forleft main coronary artery disease). In addition, this analysis of
operative factors indicated that neitherthe numberofgrafts northe completeness
of revascularization had any effect upon operative mortality.
Inordertobetterpredictoperativemortalityinindividualpatients, combinations
ofrisk factors were also examined. Two combinations appeared to be associated
with a significantly higheroperative mortality: CPB time longer than 120 minutes
andLMCD; andCPBtimegreaterthan 120minutesandanginapectorisIV(Fig. 1).
Othercombinations ofriskfactors were notsignificantly related tooperative mor-
tality.
DISCUSSION
Coronary artery bypass surgery offersgreatpromise forsymptomatic treatment
ofischemic heart disease [1-4, 8]. At the present, dataconcerning the benefits of
directmyocardialrevascularizationhavebeenamplydocumented [1-3]. However,
long-term results are notwidely available [4] because this operation has onlybeen
performed for a relatively short period of time. Reluctance to recommend this
surgery ispartially related to the risk ofopen heart surgery. This study addresses
the identification ofthose particularfactors which affectoperative mortality after
coronary bypass surgery. Clinical, anatomic, hemodynamic andoperative charac-
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Left Main Coronary Artery Disease
N = 10 N = 6
40% 67%
N= 142 N= 14
0% 7%
Angina
Classes I-Ill Class IV
N = 6 N = 10
17% 70%
N= 88 N = 68
1.1% 0%
FIG. 1. Combined riskfactors as related tooperative mortality: Left Main Coronary Artery Disease versusCardio-
pulmonary Bypass Time; Severity ofAngina versus Cardiopulmonary Bypass Time. Numbers refer to totalpatients
having both factors, percentage to mortality in each group.
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teristics of the patients were analyzed. The overall operative mortality of 5.2
percent comparesfavorablywith the range of2.3 to 12percent reportedin 15 other
surgical series [4, 8-12].
Fourfactors were found to be significantly associated with operative mortality:
(1) angina pectoris Class IV NYHA; (2) abrupt propranolol withdrawal 24 hours
prior to surgery; (3) left main coronary artery disease; and (4) cardiopulmonary
bypass timelongerthan 120minutes. Theoperativeriskforindividualpatientswith
angina Class IV was four times greater than those patients with functionally less
severe angina. Reports onthe significanceofseverityofanginasymptoms are con-
flicting; some authors reportthat severity ofanginais avery important riskfactor,
while others do not find that severe angina significantly increases operative
mortality [15-23]. It must be pointed out, that objective measurements ofangina
pectoris severity are not available; and this fact may explain in part the lack of
agreement in the findings of different medical centers. Furthermore, medical
therapy with beta blocking agents may change the functional classification for
angina pectoris in individual patients. However, it is not clear that all published
seriesarecomparableconcerningtheuseofbetablockingagents. Ourpatientswere
on optimal medical management at the time that they were classified according to
their angina symptoms.
Inthe 106patientsinwhompropranololwaswithdrawnabruptly24hourspriorto
surgery, the mortality was 6.6 percent (7/106); while in the 41 patients in whom
propranolol doses were gradually reduced over an average ofthree days and then
finally discontinued 24 hours before surgery, the operative mortality was 2.4
percent [1/41 (p < 0.05)]. Inthe 25patientsinwhompropranololwasnotusedatall
preoperatively, the operative mortality was4.0percent(1/25). Sevenpatientsdied
in the abrupt propranolol withdrawal group: six after sustaining a myocardial
infarction(firstpostoperativeweek),andoneafteracerebrovascularaccident(first
postoperativeweek). Onepatientdiedinthegradualpropranololwithdrawalgroup
due to non-cardiac cause (bleeding peptic ulcer, fourth postoperative week). One
patientdied inthe groupwhichdid notreceivepropranololbefore surgery (sudden
ventricular fibrillation, sixth postoperative week). A number of observers have
recently reported that in some patients with severe coronary artery disease
symptoms,abruptpropranololwithdrawalcancausereboundanginaandevenfatal
myocardial infarction [24-28]. These observations are, to date, anecdotal and
controlled studies have notbeenreported. However, ifthe discontinuation ofpro-
pranolol were responsibleforthe induction ofmyocardial infarction, arole forthe
drug in the prevention of myocardial necrosis in patients with coronary artery
disease mightbe implied. Myocardial infarction ascomplicationofsuddenpropra-
nololwithdrawal appears tobe related to adiminisheddrugeffectwhichleavesthe
myocardium suddenly unprotected against stress, ratherthan to residual pharma-
cological effects ofthe drug [29]. However, because the drug is known to have a
depressive actionuponmyocardialcontractility, someauthorshavestressedthatit
should be discontinued [30] before anticipated myocardial revascularization to
avoid increased morbidity and mortality in the early postoperative period. Our
observations clearly indicate that abrupt withdrawal ofpropranolol increased the
risk for coronary bypass graftingby afactoroftwo. Patients inwhompropranolol
therapy was suddenly withdrawn were chosen, depending upon the clinical
preferences ofthe referringphysician. In addition, theydid notdiffer significantly
with respect to known clinical, anatomic, or operative descriptors.
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studies withincreasedoperativemortality incoronary artery bypass grafting [9, 15,
31-33]. Themortality of25percent forpatients with LMCD observed in this study
compares with that reported by several series [9, 15, 31-33]. The number of
diseased coronary vessels were not associated with ahigher mortality. However,
patients with left maincoronary disease hadhigheroperative mortality than those
patients without left main coronary disease; suggesting that the severity of
coronary diseasemay, indeed, play animportant role in operative mortality.
The other factor found to affect operative mortality was duration ofcardiopul-
monary bypass (Table 4). Mortalities for patients on bypass for less than 90
minutes, 90-119minutes, andfor 120minutes orgreaterwere 0percent (0/119), 2.7
percent (1/37), and 50 percent (8/16), respectively.All 16 patients whose cardio-
pulmonary bypass time was longer than 120 minutes presented diffuse disease of
one or more coronary vessels. These coronary arteries received grafts with great
technical difficulty, thereby prolonging the CPB time to undesirable levels. The
only difference found between patients withcardiopulmonary bypass time longer
than 120 minutes and those with less than 120minutes, was the presence ofsevere,
diffuse distal coronary disease in those patients with prolongedcardiopulmonary
bypass (> 120 minutes). Therefore, it appears that the severity and extent of
coronary atherosclerosis rather than the duration ofcardiopulmonary bypass
determines the operative risk ofan individual patient. No relationship was found
between operative mortality and such factors as heartfailure, heart size, left
ventricular end-diastolic pressure and ejection fraction, despite data in the litera-
turetothecontrary [15, 18,34,35]. The reasonthatdepressedejectionfraction and
othermeasuresofimpairedleftventricularfunctionwerenotsignificantriskfactors
in our study is that most patients with impaired left ventricles either had the
additional procedure of mitral valve replacement or aneurysm surgery. Patients
with these combined procedures do not appear in the present study.
Statisticalanalysisoftheinterdependenceofriskfactorshasbeenincludedinthe
results sectionbecause thosefactors which dorelate tooperative mortality do not
necessarily representindependent risks. Suchanalysis has demonstrated that two
combinations offactorsappeartobeassociatedwithahighsurgicalmortality: first,
left main coronary artery disease with cardiopulmonary bypass time longer than
120 minutes; and second, anginapectoris Class IV withcardiopulmonary bypass
duration greater than 120 minutes.
The combination of LMCD and CBP time longer than 120 minutes carries a
mortality of67percent, while the absence ofthe combination carries no mortality
(Fig. 1). ThecombinationofanginapectorisClassIVandCBPtimelongerthan 120
minutes showed amortality of70percent; and when angina was less severe than
Class IV and the CBPtime was under 120 minutes, the mortality was only 1.1
percent (Fig. 1). These findings suggest, again, that the severity and extent of
coronaryartery disease and its clinicalpresentation, mainly severity and extent of
angina pectoris, are the most important determinants of operative mortality.
Clinical Implications
Ourdatasuggestthefollowingclinicalconclusions. First,patients onfullmedical
therapy with angina pectoris Class IV NYHA are at four times greater risk for
coronary bypass surgery. If these patients require a prolonged cardiopulmonary
bypass time during cardiac surgery, their risk increases over fifty times. In this
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study, the prolonged cardiopulmonary bypass time was usually attributed to the
presence ofdiffuse disease ofthe grafted vessel or vessels. Second, patients with
LMCD are 10 times atgreater risk than those without LMCD. Ifthe CPB time for
these patients during surgery extends longerthan 120minutes, theirriskincreases
significantly.
Finally, abrupt propranolol withdrawal appears to play a very important role in
operative mortality. Patients in whom propranolol therapy was stopped suddenly
showed a significantly higher mortality than those patients in whom propranolol
was gradually tapered and finally discontinued 24 hours before surgery.
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